obesity drug news today glp-1 today Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine A new study reports a

Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

A 2026 Annals of Pharmacotherapy analysis of 25 OTC patch products found zero contained semaglutide, tirzepatide, or any GLP-1 agonist

There is no scientific evidence that any over-the-counter drop can replicate the effects of physical activity or dietary changes

The longer answer involves navigating scope of practice questions, state-by-state prescribing regulations, telehealth restrictions, and the evolving economics of weight management as a service line

Support consistently answered in under a minute during my checks, and the help center covers everything from payout thresholds to device troubleshooting